JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Proceedings could be dangerous! An endocarditis clinical case].

INTRODUCTION: The authors describe a clinical case of infective endocarditis after a transrectal proceeding. Following that some questions were made: Which are the updated guidelines? Which are the risk proceedings?

THE CASE: A 55-year-old man, with aortic/pulmonary vavuloplasties and haemorrhoids developed an infectious endocarditis, by Streptococcus Viridans, after a rigid proctosigmoidoscopy. Following the endocarditis the patient suffered a pleuritis and pneumonia, those health problems justified 7 months in hospital.

DISCUSSION: The case was a co-guiltiness clinical problem which needs a multidisciplinary discussion (cardiologists, general practioners and physicians whose make invasive proceedings). The International Guidelines, with C level of evidence, omitted some potential invasive examinations and treatments so those need to be clarified. In patients with Infective Endocarditis high risk, who had haemorrhoids, before transrectal proceedings antibiotic prophylaxis may be considered.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app